APO RESEARCH · REPORT
Animal Model for Testing
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Product & engineering
Understand the product.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
Selected research
Industry Research
Animal Model for Testing Industry Research Report 2026
Market perspective
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
Read the full market overview
Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent.
In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.
Report Scope
This report quantifies the global Animal Model for Testing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Animal Model for Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Model for Testing Market by Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
Animal Model for Testing Segment by Type
Rats
Mice
Others
Animal Model for Testing Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Animal Model for Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Animal Model for Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rats
- Mice
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
Companies covered
- Charles River Laboratories
- Envigo
- Taconic Biosciences
- Jackson Laboratory
- Crown Biosciences
- Shanghai SLAC
- Shangghai Modelorg
- GenOway
- Syngene International
- Psychogenics
- Pharmaron
- Pharmalegacy
- Vitalstar Biotechnology
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Animal Model for Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Rats
- 2.2.3 Mice
- 2.2.4 Others
- 2.3 Animal Model for Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic and Research Institutes
- 2.3.3 Pharmaceutical and Biotechnology Companies
- 2.4 Assumptions and Limitations
3 Animal Model for Testing Breakdown Data by Type
- 3.1 Global Animal Model for Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Animal Model for Testing Forecasted Market Size by Type (2027-2032)
4 Animal Model for Testing Breakdown Data by Application
- 4.1 Global Animal Model for Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Animal Model for Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Animal Model for Testing Market Perspective (2021-2032)
- 5.2 Global Animal Model for Testing Growth Trends by Region
- 5.2.1 Global Animal Model for Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Animal Model for Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Animal Model for Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Animal Model for Testing Market Dynamics
- 5.3.1 Animal Model for Testing Industry Trends
- 5.3.2 Animal Model for Testing Market Drivers
- 5.3.3 Animal Model for Testing Market Challenges
- 5.3.4 Animal Model for Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Animal Model for Testing Players by Revenue
- 6.1.1 Global Top Animal Model for Testing Players by Revenue (2021-2026)
- 6.1.2 Global Animal Model for Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Animal Model for Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Animal Model for Testing Head Office and Area Served
- 6.4 Global Animal Model for Testing Players, Product Type & Application
- 6.5 Global Animal Model for Testing Manufacturers Established Date
- 6.6 Global Animal Model for Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Animal Model for Testing Market Size (2021-2032)
- 7.2 North America Animal Model for Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Animal Model for Testing Market Size by Country (2021-2026)
- 7.4 North America Animal Model for Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Animal Model for Testing Market Size (2021-2032)
- 8.2 Europe Animal Model for Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Animal Model for Testing Market Size by Country (2021-2026)
- 8.4 Europe Animal Model for Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Animal Model for Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Animal Model for Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Animal Model for Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Animal Model for Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Animal Model for Testing Market Size (2021-2032)
- 10.2 South America Animal Model for Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Animal Model for Testing Market Size by Country (2021-2026)
- 10.4 South America Animal Model for Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Animal Model for Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Animal Model for Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Animal Model for Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Animal Model for Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Charles River Laboratories
- 12.1.1 Charles River Laboratories Company Information
- 12.1.2 Charles River Laboratories Business Overview
- 12.1.3 Charles River Laboratories Revenue in Animal Model for Testing Business (2021-2026)
- 12.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
- 12.1.5 Charles River Laboratories Recent Developments
- 12.2 Envigo
- 12.2.1 Envigo Company Information
- 12.2.2 Envigo Business Overview
- 12.2.3 Envigo Revenue in Animal Model for Testing Business (2021-2026)
- 12.2.4 Envigo Animal Model for Testing Product Portfolio
- 12.2.5 Envigo Recent Developments
- 12.3 Taconic Biosciences
- 12.3.1 Taconic Biosciences Company Information
- 12.3.2 Taconic Biosciences Business Overview
- 12.3.3 Taconic Biosciences Revenue in Animal Model for Testing Business (2021-2026)
- 12.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
- 12.3.5 Taconic Biosciences Recent Developments
- 12.4 Jackson Laboratory
- 12.4.1 Jackson Laboratory Company Information
- 12.4.2 Jackson Laboratory Business Overview
- 12.4.3 Jackson Laboratory Revenue in Animal Model for Testing Business (2021-2026)
- 12.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
- 12.4.5 Jackson Laboratory Recent Developments
- 12.5 Crown Biosciences
- 12.5.1 Crown Biosciences Company Information
- 12.5.2 Crown Biosciences Business Overview
- 12.5.3 Crown Biosciences Revenue in Animal Model for Testing Business (2021-2026)
- 12.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
- 12.5.5 Crown Biosciences Recent Developments
- 12.6 Shanghai SLAC
- 12.6.1 Shanghai SLAC Company Information
- 12.6.2 Shanghai SLAC Business Overview
- 12.6.3 Shanghai SLAC Revenue in Animal Model for Testing Business (2021-2026)
- 12.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
- 12.6.5 Shanghai SLAC Recent Developments
- 12.7 Shangghai Modelorg
- 12.7.1 Shangghai Modelorg Company Information
- 12.7.2 Shangghai Modelorg Business Overview
- 12.7.3 Shangghai Modelorg Revenue in Animal Model for Testing Business (2021-2026)
- 12.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
- 12.7.5 Shangghai Modelorg Recent Developments
- 12.8 GenOway
- 12.8.1 GenOway Company Information
- 12.8.2 GenOway Business Overview
- 12.8.3 GenOway Revenue in Animal Model for Testing Business (2021-2026)
- 12.8.4 GenOway Animal Model for Testing Product Portfolio
- 12.8.5 GenOway Recent Developments
- 12.9 Syngene International
- 12.9.1 Syngene International Company Information
- 12.9.2 Syngene International Business Overview
- 12.9.3 Syngene International Revenue in Animal Model for Testing Business (2021-2026)
- 12.9.4 Syngene International Animal Model for Testing Product Portfolio
- 12.9.5 Syngene International Recent Developments
- 12.10 Psychogenics
- 12.10.1 Psychogenics Company Information
- 12.10.2 Psychogenics Business Overview
- 12.10.3 Psychogenics Revenue in Animal Model for Testing Business (2021-2026)
- 12.10.4 Psychogenics Animal Model for Testing Product Portfolio
- 12.10.5 Psychogenics Recent Developments
- 12.11 Pharmaron
- 12.11.1 Pharmaron Company Information
- 12.11.2 Pharmaron Business Overview
- 12.11.3 Pharmaron Revenue in Animal Model for Testing Business (2021-2026)
- 12.11.4 Pharmaron Animal Model for Testing Product Portfolio
- 12.11.5 Pharmaron Recent Developments
- 12.12 Pharmalegacy
- 12.12.1 Pharmalegacy Company Information
- 12.12.2 Pharmalegacy Business Overview
- 12.12.3 Pharmalegacy Revenue in Animal Model for Testing Business (2021-2026)
- 12.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
- 12.12.5 Pharmalegacy Recent Developments
- 12.13 Vitalstar Biotechnology
- 12.13.1 Vitalstar Biotechnology Company Information
- 12.13.2 Vitalstar Biotechnology Business Overview
- 12.13.3 Vitalstar Biotechnology Revenue in Animal Model for Testing Business (2021-2026)
- 12.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
- 12.13.5 Vitalstar Biotechnology Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst